Grant: Discovery Grants Program - Individual
University of British Columbia
$36,000.00
Molecular genetics and applications of a Streptomyces gene amplification system
EF 2012-13
Résumé
Streptomyces are a ubiquitous group of soil bacteria that play important roles in ecology and produce hundreds of important bioactive compounds. They are able to synthesize or degrade diverse compounds in terrestrial ecosystems. They are the most prolific known source of antibiotics (more than 2/3 of all antibiotics) as well as other metabolites having applications as herbicides, anticancer drugs, immunoregulators, and antiparasitic compounds. Genome sequencing has recently shown that each isolate is able to produce its own repertoire of 20-40 different, potentially bioactive compounds. Unfortunately, these bacteria produces less than 10% of these compounds in the laboratory. With multidrug resistant bacteria rapidly emerging, there is renewed interest in mining these pathways for new antibiotics to treat diseases caused by bacterial pathogens such as Staphylococcus, Streptococcus, Mycobacterium, and Salmonella.
We have recently identified molecular catalysts in Streptomyces that amplify the copy number of gene clusters encoding antibiotic biosynthetic pathways. These new tools include two recombination sites that can be inserted to flank a targeted gene cluster and a partner enzyme catalyzing recombination. As proof of principle, we have demonstrated that we can use our genetic tools to produce 10 tandem repeats of an antibiotic biosynthetic gene cluster, thereby increasing the production of the antibiotic by 20 fold.
Remarkably, we found that this system was also functional in E. coli. The fact that this system could catalyze events in two unrelated bacteria without additional cofactors suggests that it might be used to amplify gene clusters in a wide range of bacteria and perhaps eukaryotic hosts. To our knowledge, this represents the first system for inducible amplification of gene clusters in any organism. This new system of gene amplification promises to be a valuable tool for increasing the activities of commercially important biosynthetic or degradative pathways in a wide variety of bacteria and may also find important applications for inducible gene amplification in eukaryotic cells.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
293171-2011
Name nom
Thompson, Charles
Department département
Microbiology and Immunology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
2
Nb partie
5
Application title
Molecular genetics and applications of a Streptomyces gene amplification system
Keyword
NSERC
Application summary
Streptomyces are a ubiquitous group of soil bacteria that play important roles in ecology and produce hundreds of important bioactive compounds. They are able to synthesize or degrade diverse compounds in terrestrial ecosystems. They are the most prolific known source of antibiotics (more than 2/3 of all antibiotics) as well as other metabolites having applications as herbicides, anticancer drugs, immunoregulators, and antiparasitic compounds. Genome sequencing has recently shown that each isolate is able to produce its own repertoire of 20-40 different, potentially bioactive compounds. Unfortunately, these bacteria produces less than 10% of these compounds in the laboratory. With multidrug resistant bacteria rapidly emerging, there is renewed interest in mining these pathways for new antibiotics to treat diseases caused by bacterial pathogens such as Staphylococcus, Streptococcus, Mycobacterium, and Salmonella.
We have recently identified molecular catalysts in Streptomyces that amplify the copy number of gene clusters encoding antibiotic biosynthetic pathways. These new tools include two recombination sites that can be inserted to flank a targeted gene cluster and a partner enzyme catalyzing recombination. As proof of principle, we have demonstrated that we can use our genetic tools to produce 10 tandem repeats of an antibiotic biosynthetic gene cluster, thereby increasing the production of the antibiotic by 20 fold.
Remarkably, we found that this system was also functional in E. coli. The fact that this system could catalyze events in two unrelated bacteria without additional cofactors suggests that it might be used to amplify gene clusters in a wide range of bacteria and perhaps eukaryotic hosts. To our knowledge, this represents the first system for inducible amplification of gene clusters in any organism. This new system of gene amplification promises to be a valuable tool for increasing the activities of commercially important biosynthetic or degradative pathways in a wide variety of bacteria and may also find important applications for inducible gene amplification in eukaryotic cells.